MIRA INFORM REPORT

 

 

 

Report Date :

22.09.2008

 

IDENTIFICATION DETAILS

 

Name :

MCO HOSPITAL AIDS PRIVATE LIMITED

 

 

Registered Office :

# No. 32, 1st Main Road, Lower Palace Orchards, Bangalore – 560 003, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

27.04.1983

 

 

Com. Reg. No.:

08-5283

 

 

CIN No.:

[Company Identification No.]

U29297KA1983PTC005283

 

 

IEC No.:

0790008041

 

 

TAN No.:

(Tax Deduction & Collection Account No.)

BLRM01578D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Importer and Exporter of Surgical Sutures (both Absorbable and Non-Absorbable).

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 79000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company and has improved it’s performance.

 

Trade relations are fair. Financial position is satisfactory. Payments are usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered/Marketing Office :

No. 32, 1st Main Road, Lower Palace Orchards, Bangalore – 560003, Karnataka, India

Tel. No.:

91-80-23442167/23440232/23466783

Fax No.:

91-80-23442165

Mobile No.:

91-9448281702

E-Mail :

mcoh@bgl.vsnl.net.in

mssv@vsnl.net

mcoh@dataone.in

Area :

4000 Sq. ft

Location :

Rented

 

 

Factory :

278, Bhairidevarkoppa, Post Box No. 23, Poona-Bangalore Highway, Hubli – 580 025, Karnataka

Tel. No.:

91-836-2372624/2375467

E-Mail :

maplhblch@sify.com

Area :

30000 Sq. ft

Location :

Owned

 

 

DIRECTORS

 

Name :

Mr. Chandrakanth Gurupadappa Mahalingashettty

Designation :

Managing Director

Address :

No. 32, First Main Road, Lower Palace Orchards, Bangalore – 560 003, Karnataka, India

Date of Birth/Age :

30.10.1947

Qualification :

B.E. Civil

Date of Appointment :

27.04.1983

 

 

Name :

Mr. Vakuda Kotambail Krishnamoorthi

Designation :

Director

Address :

No.827, Opp : KHB Colony, Gandhinagar, Yelhanka, Bangalore – 560 064, Karnataka, India

Date of Birth/Age :

30.11.1957

Qualification :

B. Com.

Date of Appointment :

25.01.1993

 

 

Name :

Mrs. Vimala Chandrakanth Mahalingashettty

Designation :

Director

Address :

No. 32, First Main Road, Lower Palace Orchards, Bangalore – 560 003, Karnataka

Date of Birth/Age :

06.03.1957

Date of Appointment :

01.11.2005

 

 

KEY EXECUTIVES

 

Name :

Ms. Kavita

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 28.09.2005)

Names of Shareholders

No. of Shares

Chandrakant G Mahalingashetty

16897

Parvatama G Mahalingashetty

10

Chandrakant G Mahalingashetty (HUF)

6553

Total

23460

 

 Equity shares Breakup (percentage of total equity)

(As on 30.09.2007)                   

Category

Percentage

Directors or relatives of directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Importer and Exporter of Surgical Sutures (both Absorbable and Non-Absorbable).

 

 

Products :

·         Absorbable Surgical Sutures

·         Non-Absorbable Surgical Sutures

 

Generic Names of the Principal Products / Services of the company are

 

·         Hospital Services

·         Packing Material

 

Its’ products range include:-

 

·         Stanned Suture Chrmics

·         Needle Suture Chrmics

·         Relyon Poly Chrmics

·         Relyon Silk Chrmics

·         Strings Needles

·         Strings Standard

 

 

Brand Names :

·         REZYONCUT

·         REZYOSILK

·         REYONPOLY

·         RGZYON

·         REZYONGRTT

·         RIZYONPAC

·         RGZYON PGA.

 

 

Exports to :

·         Bangladesh

·         Srilanka

 

 

Imports from :

·         Germany

·         Korea

·         UK

 

 

Terms :

 

Selling :

Letter of Credit : 60 days

 

 

Purchasing :

Letter of Credit : 60 days

 

PRODUCTION STATUS

 

Particulars

Unit

Installed Capacity

Absorbable Surgical Sutures

DZS/Month

30000

Non-Absorbable Surgical Sutures

DZS/Month

9000

 

 

GENERAL INFORMATION

 

Suppliers :

·         Samyang Corporation, Korea

·         Azmlenter Prisgs, Dhaka

 

 

Customers :

Wholesalers and Retailers

 

It’s major customers includes :-

 

·         Public Health Departments and Government Hospitals in India

·         Private Hospitals

 

 

No. of Employees :

60

 

 

Bankers :

Union Bank of India

SSI Branch, No. 43/1, 1st Floor, Tumkur Road, Yeshwanthpur, Bangalore – 560 022, Karnataka, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

·         Maninan, Suresh, Sunder and Vittal

Chartered Accountants

Address: Agro House, Anjuman Complex, Mission Road, Bangalore, Karnataka, India

Tel. No.: 91-80-2238569

Fax No.: 91-80-2227402

 

·         D R Venkatesh

Chartered Accountants

Address: No. 28 Anjuman Complex, 2nd Floor, Lalbagh (Mission) Road, Bangalore – 560 027, Karnataka, India

 

 

Associates/Subsidiaries :

M. Apothexe Private Limited

RS 56/R/1 Chalmatti, Dharwad, Karnataka, India

Line of Business - Pharmaceuticals Formulations

 

 

CAPITAL STRUCTURE

 

(As on 30.09.2007)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

40000

Equity Shares

Rs.100/- each

Rs.4.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

23460

Equity Shares

Rs.10/- each

Rs.2.346 millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.346

2.346

2.346

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

13.468

12.164

10.966

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

15.814

14.510

13.312

LOAN FUNDS

 

 

 

1] Secured Loans

9.123

7.496

7.247

2] Unsecured Loans

7.710

7.701

7.679

TOTAL BORROWING

16.833

15.197

14.926

DEFERRED TAX LIABILITIES

0.004

0.118

0.117

 

 

 

 

TOTAL

32.651

29.825

28.355

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

5.145

4.116

4.311

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.028

0.013

0.013

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 
Inventories
7.058

11.918

7.118
 
Sundry Debtors
27.238

21.724

24.403
 
Cash & Bank Balances
1.988

3.974

0.837
 
Loans & Advances
16.713

13.971

11.233
Total Current Assets
52.997

51.587

43.591

Less : CURRENT LIABILITIES & PROVISIONS
 

 

 

 

Current Liabilities

23.457

24.966

16.945

 

Provisions

 2.062

0.925

2.615

Total Current Liabilities
25.519

25.891

19.560
Net Current Assets
27.478

25.696

24.031
 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

32.651

29.825

28.355

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2005

Sales Turnover [including other income]

48.625

 

 

Profit/(Loss) Before Tax

2.414

Provision for Taxation

0.953

Profit/(Loss) After Tax

1.461

 

 

Export Value

NA

 

 

Import Value

NA

 

 

Total Expenditure

46.211

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

NA

NA

3.00

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

NA

4.96

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

NA

5.04

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

NA

0.18

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.68

2.83

2.59

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.08

1.99

2.23

 

 

LOCAL AGENCY FURTHER INFORMATION

 

It is in trade terms with: -

 

·         Vani Enterprises

E Kottayam, 10-3-3, Sambasivapet, Guntur-522001, Andhra Pradesh, India

Tel. No: - 91-863-2328053

 

·         Nirup Pharma, New No 15, Old No P-2, Adyar Apartments, Kotturpuram, Chennai - 600085, Tamilnadu, India

Tel. No: - 91-44-24475858

 

·         Krishna Enterprises, No 58, Adarsh Nagar, Narmada Road, Jabalpur, Madhya Pradesh, India

Tel. No: - 91-761-342937

 

·         Rosebay, Dakka

 

·         Samyang Corporation

 

·         SEDL

Fixed Assets

 

·         Land

·         Building

·         Vehicles

·         Plant and machinery

 

The company has been accredited with ISO 9001: 2000 Certification

 

Form No. 8

 

Name of the company

MCO HOSPITAL AIDS PRIVATE LIMITED

Presented By

Union Bank of India

SSI Branch, Yeshwanthpur, Bangalore – 560 022, Karnataka, India

1) Date and description of instrument creating the change

12.12.1998 (Regd doc. 87/21.01.99)

Letter of Evidencing Deposit of Title Deeds.

Letter of Guarantee

Both documents relate to single charge)

2) Amount secured by the charge/amount owing on the securities of charge

Rs.10.000 millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Extn. of equitable mortgage on company’s immovable property bearing cadastel Sy. No. R S No. 56-B/1, situated at Chalmatti Village, Kalghargi Taluk, Dharwad Dist. Against various credit facilities sanctioned to Sister Concern M/s. M Apotheke Private Limited and Hypothecation of plant and machineries belonging to the company.

4) Gist of the terms and conditions and extent and operation of the charge.

Interest and Margin as applicable from time to time

Repayable on demand

5) Name and Address and description of the person entitled to the charge.

Union Bank of India

SSI Branch, Yeshwanthpur, Bangalore – 560 022, Karnataka, India

6) Date  and brief description of instrument modifying the charge

24.06.2003

Letter of Guarantee

(Corporate guarantee)

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Total limits enhanced to Rs.11.526 millions

TL : Rs.1.526 millions

CC OD : Rs.3.000 millions

UBD/Book Debts : Rs.1.000 millions

Import ILC : Rs.5.000 millions

LG : Rs.1.000 millions

Against various credit facilities sanctioned to M. Apotheke Private Limited by way of Corporate Guarantee.

All other terms and conditions incl. all existing securities to continue.

           

 

Corporate identity number of the company

U29297KA1983PTC005283

Name of the company

MCO HOSPITAL AIDS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

# No. 32, 1st Main Road, Lower Palace Orchards, Bangalore – 560 003, Karnataka, India

This form is for

Modification of charge

Type of charge

·         Book Debts

·         Movable property (not being pledge)

Particular of charge holder

Union Bank of India

SSI Branch, No. 43/1, 1st Floor, Tumkur Road, Yeshwanthpur, Bangalore – 560 022, Karnataka, India

Nature of instrument creating charge

Hypothecation Agreement of Goods and Debts (DS-06)

Date of instrument Creating the charge

29.05.2008

Amount secured by the charge

Rs.20.000 millions

Brief of the principal terms an conditions and extent and operation of the charge

·         Rate of interest

Interest at the rate of 0.25% above Union Bank of India’s Prime Lending Rate or such other rates as may be prescribed by the Bank from time to time with a minimum of 13% p.a.

 

·         Terms of repayment

On Demand

 

·         Margin

Margin 25%

 

·         Extent and operation of the charge

Hypothecation charge over entire stocks, book debts, plant and machineries and other movable assets and Mortgage of company’s immovable properties.

Particulars of the property charged

Hypothecation of present and suture stocks of sheep instestines, future threads from sheep instesrines, suture needles, other variety of future threads, packing materials, semi finished goods and finished goods, consumables, stores and spares and other movable assets of any kind, plant and machineries etc belonging to the company at No. 278, Bhairidevarakoppa, PB Road, Hubli or in transit, godowns, premises, wherever else belonging to the company and charge on all book debts, bills receivables belonging to the company. 

Particulars of the present modification

Total limits enhanced from RS.16.800 millions to Rs.20.000 millions

(CC Hypothecation Rs.12.500 millions Rs.4.300 millions and Inland/Imp : Rs.3.200 millions)

 

(With in which Cp : Rs.1.000 millions) (UDBP/IUDB Rs.2.000 millions) One way Interchangeability of LC limit to Rs.2.500 millions only restricting CC (H) at Max of Rs.15.000 millions.

 

All other terms and conditions incl. all securities to continue.

 

Web Details

 

Subject established in 1984 at Hubli, Karnataka, employs modern machineries that compliments the technical expertise of the experienced personnel. The Marketing and Administration office is situated at Bangalore.


Subject is the first Indian Company who manufactured surgical catgut sutures in India. Due to the Unmatchable quality at an economic price subject serves Most of the Government, Semi-Government, autonomous Bodies, Private hospitals and nursing homes in India for the past 20 Years.


Subject serves to their customers by a marketing network comprises of more than 50 field Executives all over India and 5 support executives from its Bangalore office.

 

Subject has more than 100 Dealers and C and F Agents all over India to deliver the products in time.


Subject products brand name “RELYON” indicates the product’s reliability; a product that can rely on.


R - Reliable for the surgeons
E - Economic for the patients
L - Lucrative for Retailers/channel partners
Y - yearns for satisfied customers
O - Offering that occupies a specific place in the market
and in the customer mind.
N - Nexus that binds different layers together
MCO produces both absorbable and non-absorbable sutures in various ranges.

 

Subject imports materials from Korea, UK, and Germany for Quality standards.

 

Subject is an ISO 9001-2000 Certified Company and owns GMP certified manufacturing facility. It holds USFDA approval for synthetic absorbable products. Subject has a well-equipped quality control lab to improve and maintain the quality.


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.46.32

UK Pound

1

Rs.83.57

Euro

1

Rs.65.90

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions